Arkolith/Insider Trading/OCEA/Form 4

Poseidon Bio, LLC

10% OwnerOcean Biomedical, Inc. (OCEA) · full profile →Form 4 · filed Feb 16, 2023
No Open-Market Flow
Open-Market Buys
$0
Open-Market Sells
$0
Net Open-Market Flow
$0
Transactions
12
6 non-derivative · 6 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Feb 14, 2023Grant(A)457K$10.00$4.6M457K
Feb 14, 2023Other(J)22.8M——0
Feb 14, 2023Other(J)457K——457K
Feb 14, 2023Other(J)457K——0
Feb 14, 2023Grant(A)22.8M$10.00$228.4M22.8M
Feb 14, 2023Other(J)22.8M——22.8M

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Feb 14, 2023Other(J)18.6M——18.6M
Feb 14, 2023Other(J)18.6M——18.6M
Feb 14, 2023Other(J)18.6M——0
Feb 14, 2023Other(J)372K——372K
Feb 14, 2023Other(J)372K——372K
Feb 14, 2023Other(J)372K——0

Transaction Codes

A
Grant / award
J
Other acquisition / disposition

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001493152-23-005367) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML